Sector
HealthcareOpen
₹507.9Prev. Close
₹505.1Turnover(Lac.)
₹703.96Day's High
₹509.5Day's Low
₹499.2552 Week's High
₹519.552 Week's Low
₹314Book Value
₹87.26Face Value
₹10Mkt Cap (₹ Cr.)
7,034.26P/E
159.87EPS
3.15Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 139.29 | 139.12 | 139.01 | 169.25 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 1,049.3 | 1,006.01 | 958.68 | 754.54 |
Net Worth | 1,188.59 | 1,145.13 | 1,097.69 | 923.79 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 608.86 | 688.33 | 586.86 | 545.03 |
yoy growth (%) | -11.54 | 17.28 | 7.67 | 15.68 |
Raw materials | -138.45 | -146.57 | -155.15 | -149.39 |
As % of sales | 22.74 | 21.29 | 26.43 | 27.4 |
Employee costs | -136.72 | -142.69 | -115.58 | -98.06 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | -51.96 | -34.57 | 33.93 | 29.3 |
Depreciation | -86.57 | -79.4 | -43.92 | -44.15 |
Tax paid | 13.51 | 12.16 | -11.98 | -9.81 |
Working capital | 242.78 | -76.35 | -42.48 | 40.7 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -11.54 | 17.28 | 7.67 | 15.68 |
Op profit growth | -36.51 | 30.42 | 7.32 | 29.58 |
EBIT growth | -77.48 | -20.26 | 34.27 | 49.42 |
Net profit growth | 259.39 | -314.13 | 27.74 | -512.27 |
Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
---|---|---|---|---|---|
Gross Sales | 1,907.87 | 1,691.41 | 1,394.78 | 1,009.19 | 1,092.34 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 1,907.87 | 1,691.41 | 1,394.78 | 1,009.19 | 1,092.34 |
Other Operating Income | 4.25 | 3.03 | 3.01 | 4.25 | 3.3 |
Other Income | 21.23 | 13.18 | 107.28 | 16.95 | 6.97 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Max Healthcare Institute Ltd MAXHEALTH | 1,096.15 | 135.56 | 1,06,482.48 | 231.3 | 0.14 | 686.11 | 81.72 |
Apollo Hospitals Enterprise Ltd APOLLOHOSP | 7,233.3 | 93.18 | 1,04,639.28 | 369.6 | 0.22 | 2,135.4 | 569.62 |
Fortis Healthcare Ltd FORTIS | 714.25 | 276.37 | 52,371.45 | 39.63 | 0.14 | 357.15 | 120.23 |
Syngene International Ltd SYNGENE | 919.7 | 85.1 | 37,373.55 | 96.6 | 0.13 | 821.3 | 107.27 |
Global Health Ltd MEDANTA | 1,175.3 | 81.7 | 31,071.53 | 104.47 | 0 | 664.61 | 113.49 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Executive Chairman
BASAVALINGA AJAIKUMAR SADASHIVAIAH
Nominee
Siddharth Patel
Executive Director
Anjali Ajaikumar Rossi
Independent Non Exe. Director
Geet Mathur
Independent Non Exe. Director
RAJAGOPALAN RAGHAVAN
Independent Non Exe. Director
Pradip M. Kanakia
Whole Time Director & CEO
Meghraj Arvindrao Gore
Nominee
AMIT SONI
Independent Non Exe. Director
Rajiv Maliwal
Company Sec. & Compli. Officer
SUNU MANUEL
Independent Director
Jeyandran Venugopal
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Healthcare Global Enterprises Ltd
Summary
Healthcare Global Enterprises Limited was originally incorporated as Curie Centre of Oncology Private Limited on March 12, 1998 at Bengaluru, Karnataka, India as a Private Limited Company. The name of the Company was changed to HealthCare Global Enterprises Private Limited on November 14, 2005. Thereafter, it was converted into a Public Limited Company and the name of the Company was changed to Healthcare Global Enterprises Limited on July 5, 2006.Presently, the Company is engaged in setting up and managing hospitals and medical diagnostic services including scientific testing and consultancy services in the pharmaceutical and medical sector. Under the HCG brand, the Company operates the largest cancer care network in India in terms of the total number of private cancer treatment centres licensed by the AERB. Under the Milann brand, it operates fertility centres. Milann fertility centres provide comprehensive reproductive medicine services, including assisted reproduction, gynaecological endoscopy and fertility preservation; and follow a multidisciplinary and technology-focused approach to diagnosis and treatment. The Milann network also operates on a model similar to our HCG network, wherein the various Milann fertility centres aim to provide medical services following established protocols with a focus on quality medical care across diagnosis and treatment. It provides comprehensive inpatient and outpatient treatments. Its key specialties include cardiology, neurology, orth
Read More
The Healthcare Global Enterprises Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹504.6 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Healthcare Global Enterprises Ltd is ₹7034.26 Cr. as of 06 Dec ‘24
The PE and PB ratios of Healthcare Global Enterprises Ltd is 159.87 and 5.75 as of 06 Dec ‘24
The 52-week high/low is the highest and lowest price at which a Healthcare Global Enterprises Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Healthcare Global Enterprises Ltd is ₹314 and ₹519.5 as of 06 Dec ‘24
Healthcare Global Enterprises Ltd's CAGR for 5 Years at 37.94%, 3 Years at 26.34%, 1 Year at 39.07%, 6 Month at 44.48%, 3 Month at 23.23% and 1 Month at 6.42%.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice